Fungal secondary metabolites are a rich source for drug development.
Extension of fungal natural product portfolio by generation of non-natural compounds.
Description of past and recent strategies for fungal natural product diversification.
Covering examples from current state-of-the-art biosynthetic approaches.
Discussion of future challenges and perspectives.